Friday, October 26
11:00 a.m. - 1:30 p.m.
Topics include: Attention-Deficit/Hyperactivity Disorder, External Consultation/Schools/Special Education, Feeding/Eating/Sleep Disorders, Health Care Economics/Managed Care/Practice Issues, Pharmacotherapy, Substance-Related Disorders,
D1
The Use of Research Payments by Adolescent Substance Abusers
Christian C. Thurstone, M.D. (M)
Denver Health and Hospital Authority
Denver, CO USA
Marcel De Dios, M.S.
David Salinas, B.A.
Lainie Friedman Ross, M.D., Ph.D.
(NIDA/AACAP Physician Scientist Program in Substance Abuse K12 Award)
D2
Brief Intervention in Substance Use among Adolescent Psychiatric Patients
Javier Goti, M.D.
Hospital Clinic Universitari de Barcelona
Barcelona, Spain
Rosa Diaz, Ph.D.
Lourdes Serrano, Ph.D.
Laura Gonzalez, Ph.D.
Rosa Calvo, M.D., Ph.D.
Josefina Castro, M.D., Ph.D.
Antoni Gual, M.D., Ph.D.
D3
Concordance Between the mFTQ and DSM Smoking Dependence
Timothy E. Wilens, M.D. (M)
Massachusetts General Hospital
Boston, MA
Michael Vitulano, B.A.
Himanshu P. Upadhyaya, MBBS, M.S. (M)
Joel J. Adamson, B.A.
Joseph Biederman, M.D. (M)
D4
Atomoxetine Treatment of Adults With ADHD and Comorbid Alcohol Abuse Disorder
Timothy E. Wilens, M.D. (M)
Massachusetts General Hospital
Boston, MA
Lenard A. Adler, M.D.
Margaret D. Weiss, M.D., Ph.D. (M)
Kathleen T. Brady, M.D., Ph.D.
Janet L. Ramsey, M.S., M.P.H.
D. Renard
Albert J. Allen, M.D., Ph.D. (M)
D5
Efficacy and Safety of Methylphenidate Transdermal System in ADHD Subjects
Timothy E. Wilens, M.D. (M)
Massachusetts General Hospital
Boston, MA
Samuel W. Boellner, M.D.
Frank A. Lopez, M.D.
John Turnbow, M.D.
Sharon B. Wigal, Ph.D.
Joseph Kerkering, M.B.A.
D6
Reliability and Validity of the Weiss Functional Impairment Rating Scale
Margaret D. Weiss, M.D., Ph.D. (M)
University of British Columbia
Vancouver, BC Canada
Brian L. Brooks, Ph.D.
British Columbia Mental Health Services
Coquitlam, BC Canada
Grant L Iverson, Ph.D.
Bobbie Lee, Msc
Ruth A Dickson, M.D.
Christopher Gibbins, Ph.D.
Michael B. Wasdell, M.A.
D7
Atomoxetine Treatment for ADHD: Effects on Cigarette Smoking in Adults
Himanshu P. Upadhyaya, MBBS, M.S. (M)
Medical University of South Carolina
Charleston, SC
Todd Durrell, M.D.
Catherine A. Martin, M.D. (M)
Alessandra N. Kazura, M.D. (M)
David Baron, M.S.Ed.
Martin Paczkowski, M.P.H.
David W. Williams, M.S.
Kory J. Schuh, Ph.D.
D8
CYP2D6 Metabolizer Status and Atomoxetine Dosing in Children and Adolescents with ADHD
Paula T. Trzepacz, M.D.
Lilly Research Laboratories
Indianapolis, IN
David W. Williams, M.S.
Peter D. Feldman, Ph.D.
Jennifer W. Witcher, M.D.
Jan K. Buitelaar, M.D., Ph.D. (M)
D9
Safety of OROS Methylphenidate in Adults with ADHD
Sally A. Berry, M.D., Ph.D.
Johnson & Johnson Pharmaceutical Research and Development
Titusville, NJ
Camille Orman, Ph.D.
Kimberly M. Cooper, M.S.
Lenard A. Adler, M.D.
H. Lynn Starr, M.D.
Maria Vazquez-Gragg, M.D.
D10
Association between Insomnia and ADHD during a Followup Study
Craig B.H. Surman, M.D., Eric O. Mick, Sc.D., Joseph Biederman, M.D.
Massachusetts General Hospital
Boston, MA
D11
Analysis of the Abuse Potential of ADHD Treatments Using DAWN
H. Lynn Starr, M.D.
Ortho-McNeil Janssen, LLC
Fort Washington, PA
John J. Coleman, M.A., M.S.
Robert DuPont, M.D.
Peter B. Bensinger
Patrick E. Ciccone, M.D.
D12
Time of Day Preference and Attention Deficit Hyperactivity Disorder in Boys
Noam Soreni, M.D.
McMaster University
Hamilton, ON Canada
Russell J. Schachar, M.D. (M) (CM)
David Goldstein, Ph.D.
Lynn Hasher, Ph.D.
D13
Test/Re-test Reliability of Neuropsychological Tasks in ADHD
Sarah A. Seth, MBChB, MRCPsych
University of Dundee
Dundee, Scotland
Sinead M. Rhodes, M.Litt, B.A., Ph.D.
Keith Matthews, M.D., Ph.D.
David R. Coghill, MBChB, M.D., MRCPsych (M)
D14
Insomnia with Triple-Bead Mixed Amphetamine Salts in Adults with ADHD
Thomas Roth, Ph.D.
Henry Ford Hospital Sleep Clinic
Detroit, MI USA
Thomas J. Spencer, M.D. (M)
Arthur Silverberg, Ph.D.
Sharon H. Youcha, M.D.
D15
ADHD: The Impact on Parent’s and Children’s Quality of Life
Maugan Rimmer, MBChB, MRCPsych, PGDip
University of Dundee
Dundee, Scotland
Claire Campbell
David R. Coghill, MBChB, M.D., MRCPsych (M)
D16
Biogenetic Temperament and Character Profiles in ADHD Symptoms in Korean
Sung Kun Park, M.D.
Seoul National University Hospital
Seoul, Korea
Soo-Churl Cho, M.D., Ph.D. (M)
Bong-Nyun Kim, M.D., Ph.D. (M)
Jae-Won Kim, M.D.
D17
Effects of CBT on Children with ADHD
Yoon Phaik Ooi, Ph.D.
Institute of Mental Health
Singapore,
Rebecca P. Ang, Ph.D.
Daniel S. Fung, MBBS, MMed., FAMS (M)
Yiming Cai, MBBS, MMed., FAMS
Geraldine Wong
D18
Stimulant Dosing in the Community Treatment of Children with ADHD
Mark Olfson, M.D.
Columbia University
New York, NY
D19
Methylphenidate Attenuates Multi-Second Spikes in Activity of ADHD Boys
Kyoko Ohashi, Ph.D.
McLean Hospital
Belmont, MA
Ann Polcari, Ph.D., R.N., C.S.
Cynthia E. McGreenery
Elizabeth A. Valente, M.A.
Martin H. Teicher, M.D., Ph.D.
D20
Maternal Smoking During Pregnancy: Inattention and Hyperactivity/Impulsivity among Their Children
Yoko Nomura, Ph.D.
Mount Sinai Hospital
Chicago, IL
Taneka Wellington
Katia Castelli
Khushmand Rajendran, M.S.W.
David J. Marks, Ph.D.
Dione Healey, Ph.D.
Jeffrey M. Halperin, Ph.D.
D21
Clinical Evaluation of Triple-Bead Mixed Amphetamine Salts in Adult ADHD
David W. Goodman, M.D.
Johns Hopkins University
Baltimore, MD
Thomas J. Spencer, M.D. (M)
D22
Transdermal Methylphenidate Pharmacokinetics in ADHD Patients Using Two Applications
Mario A. Gonzalez, Ph.D.
P’Kinetics, International Inc.
Pembroke Pines, FL
Dawn A. Campbell, B.A.
Jonathon Rubin, M.D., M.B.A.
D23
Methylphenidate Induced Increases in Smoking: Immediate- Release vs. Sustained-Release
Paul E.A. Glaser, M.D., Ph.D. (M)
University of Kentucky
Louisville, KY
Andrea R. Vansickel, B.A.
William W. Stoops, Ph.D.
Craig R. Rush, Ph.D.
D24
Atomoxetine Treatment of ADHD: Symptomatic, Academic, Cognitive, and Functional Outcomes
Ruth A Dickson, M.D.
Eli Lilly Canada
Danforth, Canada
Bobbie Lee, Msc
Atilla Turgay, M.D., FRCP (M)
Samuel Chang, M.D.
Hubert P. White, M.D.
Lori A. Davis, Ph.D.
Michael B. Wasdell, M.A.
Alan Y. Yoshioka, Ph.D.
Margaret D. Weiss, M.D., Ph.D. (M)
D25
Assessing the Attitudes of ADHD Adolescents Toward Stimulant Medication Usage
Margaret T. Davis, B.A.
University of Virginia
Charlottesville, VA
Brian S. Cox, B.S.
Roger C. Burket, M.D. (M)
D26
ADHD Adolescent Drivers’ Risk Taking and Driving Mishaps
Brian S Cox, B.S.
University of Virginia
Margaret T Coleman, B.A.
Roger C. Burket, M.D. (M)
D27
Visual Inattention Contributes Dysfunction of Emotional Facial Recognition in ADHD
Kim Bum Jo, M.D.
Sungkyunkwan University School of Medicine
Seoul, Korea
Dongwon Shin, M.D., Ph.D.
S. J. Lee, Ph.D.
D31
Frequency and Correlates of Inappropriate Pediatric Psychiatric Emergency Visits
Erin R. Callahan, M.A.
Albert Einstein College of Medicine
Bronx, NY
Anne M. Frederickson, M.D. (R)
Robert Dicker, M.D. (M)
Christoph U. Correll, M.D. (M)
D32
Payers Influence on Length of Stay for Depression Among Children
David A. Sclar, B.Pharm, Pharm.D.
Washington State University
Pullman, WA
Linda M. Robison, M.S.P.H.
Corrine Gavrun, M.B.A.
Tracy L. Skaer, B.Pharm, Pharm.D.
D33
Strategies to Manage Child Mental Health Waitlists in Canada
John D. McLennan, M.D., Ph.D., FRCP (M)
University of Calgary
Calgary, AB Canada
Mary Perry
Charlotte Waddell, M.D.
John Lavis, M.D., Ph.D.
D34
Child Characteristics and Outcomes from a School-Health Partnership Program
John D. McLennan, M.D., Ph.D., FRCP (M)
University of Calgary
Calgary, AB Canada
Susan Huculak, M.A.
Faith Ng, B.Sc.
Karolina Kowalewski
D35
Differences in Dominican Children with and without Failure to Thrive
John D. McLennan, M.D., Ph.D., FRCP (M)
University of Calgary
Calgary, AB Canada
Ashley Farrelly
Julianne Yip
D38
The Validity of the Eating Disorder Examination in Discriminating between Adolescents with and without Eating
Problems in Ireland
Leonie M. Keogh, B.A., M.Litt
University College Dublin
Dublin, Ireland
Barbara Dooley, Ph.D., B.A.
Fiona McNicholas, M.D., MRCPsych (M)
D39
Psychiatric Comorbidity and Behavioral Problems in Overweight Mexican-American Children
Amanda A. Drews, Ph.D.
UCLA - Semel Institute for Neuroscience and Human Behavior
Los Angeles, CA
Brie A. Moore, Ph.D.
Sarika Thakur, M.A., M.P.H.
Patricia Reyes, B.A.
Diana Hulzar, B.A.
Zoe Martinez, M.D., Ph.D. (M)
Alejandra G. Contreras
James T. McCracken, M.D. (M)
D40
Effectiveness of Cognitive Behavioral Therapy in a Multi-modal Group Therapy-Based Programme for Inpatients with Anorexia Nervosa
Alison Darcy, M.B.A., M.Litt
University College Dublin
Dublin, Ireland
Barbara Dooley, Ph.D., B.A.
Zita Radmall-Quirke
Terence Larkin
Imelda Redmond
Leonie M. Keogh, B.A., M.Litt
D41
Body Dissatisfaction, Self-Esteem, and Depression in Korean Obese Children
Shin Min-Sup, Ph.D.
Seoul National University
Seoul, Korea
Shin Na-Young, M.A.
D42
Do Eating Disorders Experience Dysfunctional Body Image on the Others?
Elena Moreno
Hospital Clinic de Barcelona
Barcelona, Spain
Lorena Gomez, M.D.
Teresa Plana, M.D.
Susana Andres, Ph.D.
Luisa Lazaro, M.D., Ph.D.
Josefina Castro-Fornieles, M.D., Ph.D.
D43
Differences in Asian, Hispanic and Caucasian Adolescents with Eating Disorders
Rebecka Peebles, M.D.
Stanford University Medical Center
Palo Alto, CA
Jenny L. Wilson, B.A.
Cristin D. Runfola, B.A.
Kristina K. Hardy, Ph.D.
James D. Lock, M.D., Ph.D. (M)
D44
An Integrative Psychotherapeutic Outpatient Program for Feeding Disorders
Hanna L. Ratjen, M.D.
Hospital for Sick Children
Toronto, ON Canada
Jean-Victor P. Wittenberg, M.D., FRCPC (CM)
D45
Pilot Study of Olanzapine in the Treatment of Anorexia Nervosa
Vivian Kafantaris, M.D. (M)
The Zucker Hillside Hospital
Glen Oaks, CA
Ellen Leigh, Ph.D.
Alison L. Berest, B.S.
Stanley Hertz, M.D. (M)
Wendy Meyer-Sterling
Janet Schebendach
Kim A. Gallelli, Ph.D.
Ema Saito, M.D. (M)
Neville Golden, M.D.
Anil Malhotra, Ph.D.
D46
Food for Thought; Using the EDEQ and DEBQ to Assess Psychological Concomitants of Overweight and Obese
Status among a Community Sample of Irish Adolescents
Aoife Menton, B.A.
University College Dublin
Dublin, Ireland
D47
Eating Problems in Children and Adolescents: An Epidemiological Study of Irish Adolescents
Fiona McNicholas, M.D., MRCPsych (M)
Our Lady’s Hospital for Sick Children
Dublin, Ireland
Barbara Dooley, Ph.D., B.A.
Leonie M. Keogh, B.A., M.Litt
D48
Transient Ischaemic Attack in Child on Risperidone and Clonidine
Fiona McNicholas, M.D., MRCPsych (M)
Our Lady’s Hospital for Sick Children
Dublin, Ireland
Farhana Motala, MRCPsych
D49
Placebo Controlled Trial of Divalproex Versus Lithium for Bipolar Disorder
Robert A. Kowatch, M.D. (M)
Cincinnati Children’s Hospital Medical Center
Cincinnati, OH
Robert L. Findling, M.D. (M)
Russell E. Scheffer, M.D. (M)
Kevin E. Stanford, M.P.H.
D50
Atypical Antipsychotics and Metabolic Syndrome in Residential Patients
Michelle S. Guchereau, M.D.
University of Texas Health Science Center at San Antonio
San Antonio, TX
Steven R. Pliszka, M.D. (M)
James Mintz, Ph.D.
Cheng-Pin Wang, Ph.D.
Vanessa Wong, M.D.
D51
Measuring Adherence to Stimulant Treatment in Children with ADHD
Amy Gajaria, B.A.
The Hospital for Sick Children
Toronto, ON Canada
Anna Skyba, C.N.S., C.N.P.
Shirley X. Chen, M.D., M.P.H.
Alice Charach, M.D., FRCP(C), M.Sc. (M)
D52
Aripiprazole in Children and Adolescents with Tourette’s Syndrome
Wan-Seok Seo, M.D., Ph.D.
YeungNam University Hospital
Namgu, Daegu, Korea
Huyng Mo Sung, M.D., Ph.D.
Hyun Seok Sea, M.D.
Bai Dai Seog, Ph.D.
D53
ADHD Impact Treatment Across the Day: Pan Euorpean Survey
Edmund J. Sonuga-Barke, Ph.D.
University of Southampton
James M. Swanson, M.D.
Mieke Vandenberghe, M.D.
Judy Hunt, M.B.A., M.H.S.
D54
Differences in Suicidality in Hispanic Versus Non-Hispanic Adolescents
Ronald Ledo, M.D. (R)
Columbia University College of Physicians and Surgeons
New York, NY
Michelle Acosta, Ph.D.
Marjorie Waldbaum, M.D. (M)
D55
Alcohol and Tobacco Use among School Students in South Korean
Yong-sil Kweon, M.D., Ph.D.
Catholic University of Korea
Seoul, Korea
Hae-Kook Lee, M.D.
Chung-Tai Lee, M.D.
Kyung-Uk Lee, M.D.
D56
Momentary Sampling Assessment of Affect and Marijuana Use in Youth
Shimrit Koren, B.A.
Children’s Hospital Boston
Boston, MA
Carl de Moor, Ph.D.
Parul Aneja, MS
John R. Knight, M.D. (M)
Lydia A. Shrier, M.D., MPH
D57
Correlation of Eating Disorder Symptoms with Substance Dependence in Adolescents
Janelle E Arias, M.D. (R)
Yale Child Study Center
New Haven, CT
Josephine Hawke, Ph.D.
Yifrah Kaminer, M.D. (M)
D58
Substance Use in Adolescents with Mood and Anxiety Disorders
Rosa Calvo, M.D., Ph.D.
Hospital Clinic Universitari de Barcelona
Barcelona, Spain
Rosa Diaz, Ph.D.
Josefina Castro-Fornieles, M.D., Ph.D.
Javier Goti, M.D.
Laura Gonzalez, Ph.D.
Lourdes Serrano, Ph.D.
Antoni Gual, M.D., Ph.D.
D59
Martial Arts as Early Intervention for Teen Drug Abuse--The Process of Behavioral Therapy Development
Robert D. Davies, M.D.
University of Colorado Health Sciences Center
Denver, CO
Ashley Kayser
Constance A. Klein, MSW, LCSW
Susan K. Mikulich-Gilbertson, Ph.D.
Shannon K. Stover, B.S.
Fariba Madani, M.A.
Cyrus Madani
Andrew Schneider
Paula D. Riggs, M.D. (M)
D60
Age and Gender Differences in Substance-Related Motor Vehicle Risk
Cristina Toba, M.D. (R)
Columbia University College of Physicians and Surgeons
New York, NY
Michelle Acosta, Ph.D.
Marjorie Waldbaum, M.D. (M)
D61
Motivational Enhancement Therapy for Psychiatric Youth with Substance Use Disorders
Robert P. Milin, M.D., FRCPC (M)
Royal Ottawa Hospital
Ottawa, ON Canada
Glenda Dare, Ph.D.
Tracey Skilling, Ph.D.
Chris Wekerle, Ph.D.
Selena Walker, M.A.
